MyFinsight
Home
About
Contact
nvcr: the income statement
Download
Download image
Other International
Markets
$15,706K
JP
$9,385K
FR
$19,620K
DE
$20,286K
Net income (loss)
-$37,270K
(-21.92%↓ Y/Y)
CN
$5,598K
International Markets
$64,997K
US
$96,609K
Income tax
$7,248K
(-19.33%↓ Y/Y)
Income (loss) before
income tax
-$30,022K
(-39.09%↓ Y/Y)
Financial income
(expenses), net
$5,999K
(-42.90%↓ Y/Y)
Net revenues
$167,204K
(7.81%↑ Y/Y)
Operating income (loss)
-$36,021K
(-12.24%↓ Y/Y)
Gross profit
$122,475K
(2.30%↑ Y/Y)
Cost of revenues
$44,729K
(26.45%↑ Y/Y)
Total operating costs
and expenses
$158,496K
(4.40%↑ Y/Y)
General and
administrative
$45,921K
(14.51%↑ Y/Y)
Sales and marketing
$58,546K
(-2.15%↓ Y/Y)
Research, development and
clinical studies
$54,029K
(4.14%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
NovoCure Ltd (NVCR)
NovoCure Ltd (NVCR)